Cargando…

Epigenetic state determines the in vivo efficacy of STING agonist therapy

While STING-activating agents have shown limited efficacy in early-phase clinical trials, multiple lines of evidence suggest the importance of tumor cell-intrinsic STING function in mediating antitumor immune responses. Although STING signaling is impaired in human melanoma, its restoration through...

Descripción completa

Detalles Bibliográficos
Autores principales:	Falahat, Rana, Berglund, Anders, Perez-Villarroel, Patricio, Putney, Ryan M., Hamaidi, Imene, Kim, Sungjune, Pilon-Thomas, Shari, Barber, Glen N., Mulé, James J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033671/ https://www.ncbi.nlm.nih.gov/pubmed/36949064 http://dx.doi.org/10.1038/s41467-023-37217-1

Ejemplares similares

Epigenetic dysregulation of immune-related pathways in cancer: bioinformatics tools and visualization
por: Berglund, Anders, et al.
Publicado: (2021)

Suppression of STING Signaling through Epigenetic Silencing and Missense Mutation Impedes DNA-Damage Mediated Cytokine Production
por: Konno, Hiroyasu, et al.
Publicado: (2018)

Sirtuins are crucial regulators of T cell metabolism and functions
por: Hamaidi, Imene, et al.
Publicado: (2022)

Induction of Tertiary Lymphoid Structures With Antitumor Function by a Lymph Node-Derived Stromal Cell Line
por: Zhu, Genyuan, et al.
Publicado: (2018)

STING: infection, inflammation and cancer
por: Barber, Glen N.
Publicado: (2015)

Mathematical modeling of radiotherapy and its impact on tumor interactions with the immune system
por: Bekker, Rebecca Anne, et al.
Publicado: (2022)

STING Agonists as Cancer Therapeutics
por: Amouzegar, Afsaneh, et al.
Publicado: (2021)

STING signaling and host defense against microbial infection
por: Ahn, Jeonghyun, et al.
Publicado: (2019)

Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA
por: Chang, Jiajia, et al.
Publicado: (2023)

STING an Endoplasmic Reticulum Adaptor that Facilitates Innate Immune Signaling
por: Ishikawa, Hiroki, et al.
Publicado: (2008)

The STING pathway and regulation of innate immune signaling in response to DNA pathogens
por: Ishikawa, Hiroki, et al.
Publicado: (2010)

Trial watch: STING agonists in cancer therapy
por: Le Naour, Julie, et al.
Publicado: (2020)

Effects of STING stimulation on macrophages: STING agonists polarize into “classically” or “alternatively” activated macrophages?
por: Ohkuri, Takayuki, et al.
Publicado: (2017)

ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance
por: Jang, Su Chul, et al.
Publicado: (2021)

The 12-CK Score: Global Measurement of Tertiary Lymphoid Structures
por: Li, Roger, et al.
Publicado: (2021)

Extremely potent immunotherapeutic activity of a STING agonist in the B16 melanoma model in vivo
por: Corrales, Leticia, et al.
Publicado: (2013)

STING Agonists/Antagonists: Their Potential as Therapeutics and Future Developments
por: Guerini, Danilo
Publicado: (2022)

Activation of STING requires palmitoylation at the Golgi
por: Mukai, Kojiro, et al.
Publicado: (2016)

Tumor-Associated Tertiary Lymphoid Structures: Gene-Expression Profiling and Their Bioengineering
por: Zhu, Genyuan, et al.
Publicado: (2017)

Examination of MARCO Activity on Dendritic Cell Phenotype and Function Using a Gene Knockout Mouse
por: Komine, Hiroshi, et al.
Publicado: (2013)

Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
por: Motedayen Aval, Leila, et al.
Publicado: (2020)

Combination of Irreversible Electroporation and STING Agonist for Effective Cancer Immunotherapy
por: Go, Eun-Jin, et al.
Publicado: (2020)

Probiotic Engineering and Targeted Sonoimmuno‐Therapy Augmented by STING Agonist
por: Lu, Dan, et al.
Publicado: (2022)

Anticancer Effect of STING Agonist-Encapsulated Liposomes on Breast Cancer
por: Zhang, Jibing, et al.
Publicado: (2023)

Structural and Biological Evaluations of a Non-Nucleoside STING Agonist Specific for Human STING(A230) Variants
por: Tang, Zhichao, et al.
Publicado: (2023)

Synergistic Effects of Azithromycin and STING Agonist Promote IFN-I Production by Enhancing the Activation of STING-TBK1 Signaling
por: Petcharat, Kanoktip, et al.
Publicado: (2023)

Paradoxical epigenetic regulation of XAF1 mediates plasticity towards adaptive resistance evolution in MGMT-methylated glioblastoma
por: Wu, Qiong, et al.
Publicado: (2019)

Combination of STING Pathway Agonist With Saponin Is an Effective Adjuvant in Immunosenescent Mice
por: Vassilieva, Elena V., et al.
Publicado: (2019)

STING agonist promotes CAR T cell trafficking and persistence in breast cancer
por: Xu, Nuo, et al.
Publicado: (2020)

Prolonged activation of innate immune pathways by a polyvalent STING agonist
por: Li, Suxin, et al.
Publicado: (2021)

Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine Glioblastoma
por: Boudreau, C. Elizabeth, et al.
Publicado: (2021)

Identification of MSA-2: An oral antitumor non-nucleotide STING agonist
por: Liu, Jianhua, et al.
Publicado: (2021)

Novel Poxin Stable cGAMP‐Derivatives Are Remarkable STING Agonists
por: Stazzoni, Samuele, et al.
Publicado: (2022)

Tumor-targeted delivery of a STING agonist improves cancer immunotherapy
por: Wu, You-tong, et al.
Publicado: (2022)

Computational study on new natural compound agonists of stimulator of interferon genes (STING)
por: Zhong, Sheng, et al.
Publicado: (2019)

Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity
por: Lemos, Henrique, et al.
Publicado: (2020)

Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy
por: Bhatnagar, Shubhmita, et al.
Publicado: (2022)

Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug Conjugates
por: Duvall, Jeremy R., et al.
Publicado: (2023)

Expression profile of genes regulated by activity of the Na-H exchanger NHE1
por: Putney, Luanna K, et al.
Publicado: (2004)

STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques
por: Yamamoto, Takuya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s3et1jibgsevvj1ilb60f4072m